EUVIMEDEUVIMED entdecken
Open Access

Prognostic significance of HALP score in İdiopathic Pulmonary Fibrosis-related mortality.

Mustafa Çolak iD, Hikmet Çoban iD, Nurhan Sarıoğlu iD, Merve Yumrukuz Şenel iD, Fuat Erel iD

Sarcoidosis vasculitis and diffuse lung diseases · 25.06.2025 · 42 (2) · 16003-16003

DOI: 10.36141/svdld.v42i2.16003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sarcoidosis vasculitis and diffuse lung diseases, erschienen am 25.06.2025. Verfasst von Mustafa Çolak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chest Disease, University of Balikesir, Turkey. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIM: To investigate the prognostic value of the HALP (Hemoglobin, Albumin, Lymphocyte, and Platelet) score for mortality in patients with Idiopathic Pulmonary Fibrosis (IPF). METHODS: From November 2020, 39 patients with IPF were followed for a duration of 3 years. At the end of 3 years, the relationship between the initial HALP score and mortality was investigated. RESULTS: Thirty-nine patients diagnosed with IPF were included in the study, 30 of whom were male. The average age of all patients was 68.79±7.08. At the end of the three-year follow-up period, 12 patients (33.3%) had died. When comparing patients who died and those who survived at the end of three years; significant differences were found in age, neutrophil, albumin, HALP score, FEV1%, FVC%, DLCO%, GAP score, and 6 MWD. ROC analysis for the HALP score's predictive value for mortality yielded an AUC of 0.743 and p=0.011. For a cut-off value of HALP≤30.5, p=0.01, sensitivity and specificity were 61.54% and 92.31%, respectively. Multivariate analysis for predicting mortality found HALP≤30.50 as a significant risk factor (p=0.046). An increase of one monad at the HALP cut-off (≤30.50) score level reduced the risk of death by 9.57 times. It was observed that FVC%, DLCO% and 6 MWD were not risk factors in predicting mortality. (p=0.30, p=0.08, p=0.07). CONCLUSIONS: Our study suggests that the HALP score may serve as a negative prognostic biomarker that can be used to predict mortality in cases with IPF.

Schlagwörter

idiopathic pulmonary fibrosisHALP scoremortality predictionprognostic factorshemoglobinserum albuminlymphocyte countplatelet countrisk factors

Autor:innen und Institutionen

  • Department of Chest Disease, University of Balikesir, Turkey.

ORCID-Profile: Mustafa Çolak, Hikmet Çoban, Nurhan Sarıoğlu, Merve Yumrukuz Şenel, Fuat Erel

Zitieren

APA

Çolak, M., Çoban, H., Sarıoğlu, N., Yumrukuz Şenel, M., & Erel, F. (2025). Prognostic significance of HALP score in İdiopathic Pulmonary Fibrosis-related mortality. Sarcoidosis vasculitis and diffuse lung diseases, 42(2), 16003-16003. https://doi.org/10.36141/svdld.v42i2.16003

Vancouver

Çolak M, Çoban H, Sarıoğlu N, Yumrukuz Şenel M, Erel F. Prognostic significance of HALP score in İdiopathic Pulmonary Fibrosis-related mortality. Sarcoidosis vasculitis and diffuse lung diseases. 2025;42(2):16003-16003. doi:10.36141/svdld.v42i2.16003

BibTeX
@article{olak2025,
  author = {Çolak, Mustafa and Çoban, Hikmet and Sarıoğlu, Nurhan and Yumrukuz Şenel, Merve and Erel, Fuat},
  title = {Prognostic significance of HALP score in İdiopathic Pulmonary Fibrosis-related mortality},
  journal = {Sarcoidosis vasculitis and diffuse lung diseases},
  year = {2025},
  volume = {42},
  number = {2},
  pages = {16003--16003},
  doi = {10.36141/svdld.v42i2.16003}
}
Kostenlos starten →